JP Morgan Cazenove today reaffirms its overweight investment rating on Intermediate Capital Group PLC (LON:ICP) and cut its price target to 1400p (from 1800p).
Respiratory disease focused Synairgen said it had received expedited regulatory approvals to conduct a trial of an inhaled formulation to treat COVID-19 patients.
Attractions group Live Company said subsidiary Brick Live International had formed an agreement with The Copyrights to produce a touring interactive experience based on the...